Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]RCCB6 PET/CT Imaging in Kidney Cancer
NCT06680089Phase 2Recruiting
- Sponsor
- Renji Hospital
- Start
- Nov 2024
- Primary completion
- Nov 2026
- Modality
- CA (Contrast Agent), Immunodiagnostic
- Countries
- 1
01
Overview
A Phase 2 trial of RCCB6 in kidney cancer, sponsored by Renji Hospital. Started Nov 2024; status: recruiting.
02
Drugs
RCCB6
03
Conditions
kidney cancer
Beyond the preview
Go deeper on NCT06680089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06680089.